|
|
||||||||
Journal of Applied Physiology, Vol 64, Issue 6 2532-2537, Copyright © 1988 by American Physiological Society
ARTICLES |
P. A. Minette and P. J. Barnes
Department of Thoracic Medicine, Cardiothoracic Institute, London, United Kingdom.
We have investigated whether prejunctional inhibitory muscarinic receptors ("autoreceptors") exist on cholinergic nerves in human airways in vitro and whether guinea pig trachea provides a good model for further pharmacological characterization of these receptors. Pilocarpine was used as a selective agonist and gallamine as a selective antagonist of these autoreceptors. Acetylcholine (ACh) release from postganglionic cholinergic nerves was elicited by electrical field stimulation (EFS) (40 V, 0.5 ms, 32 Hz). In human bronchi, pilocarpine inhibited the contractile response to EFS in a dose-related fashion; the dose inhibiting 50% of the control contraction was 2.2 +/- 0.4 x 10(-7) (SE) M (n = 22), and the inhibition was 96% at 3 x 10(-5) M. The inhibitory effects of pilocarpine were antagonized by gallamine in a dose-related fashion. The results were qualitatively the same in the guinea pig. Gallamine significantly enhanced the contractile response to EFS in the guinea pig, whereas pirenzepine failed to do so, which suggests that M2-receptors are involved. We conclude that prejunctional muscarinic receptors that inhibit ACh release are present on cholinergic nerves in human airways and that guinea pig trachea is a good model for further pharmacological characterization of these receptors, which appear to belong to the M2-subtype.
This article has been cited by other articles:
![]() |
N. Durcan, R. W. Costello, W. G. McLean, J. Blusztajn, B. Madziar, A. G. Fenech, I. P. Hall, G. J. Gleich, L. McGarvey, and M.-T. Walsh Eosinophil-Mediated Cholinergic Nerve Remodeling Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 775 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Proskocil and A. D. Fryer {beta}2-Agonist and Anticholinergic Drugs in the Treatment of Lung Disease Proceedings of the ATS, November 1, 2005; 2(4): 305 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Johnson Corticosteroids: Potential {beta}2-Agonist and Anticholinergic Interactions in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lein and A. D. Fryer Organophosphorus Insecticides Induce Airway Hyperreactivity by Decreasing Neuronal M2 Muscarinic Receptor Function Independent of Acetylcholinesterase Inhibition Toxicol. Sci., January 1, 2005; 83(1): 166 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Lee, A. D. Fryer, N. van Rooijen, and D. B. Jacoby Role of macrophages in virus-induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1255 - L1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Fryer, P. J. Lein, A. S. Howard, B. L. Yost, R. A. Beckles, and D. A. Jett Mechanisms of organophosphate insecticide-induced airway hyperreactivity Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L963 - L969. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Coulson, D. B. Jacoby, and A. D. Fryer Insulin Regulates Neuronal M2 Muscarinic Receptor Function in the Ileum of Diabetic Rats J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 760 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Adamko, A. D. Fryer, B. S. Bochner, and D. B. Jacoby CD8+ T Lymphocytes in Viral Hyperreactivity and M2 Muscarinic Receptor Dysfunction Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 550 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sarria, E. Naline, Y. Zhang, J. Cortijo, M. Molimard, J. Moreau, P. Therond, C. Advenier, and E. J. Morcillo Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1125 - L1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Jacoby Virus-Induced Asthma Attacks JAMA, February 13, 2002; 287(6): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hirose, I. Aoki, T. Kimura, T. Fujikawa, T. Numazawa, K. Sasaki, A. Sato, T. Hasegawa, M. Nishikibe, M. Mitsuya, et al. Pharmacological Properties of (2R)-N-[1-(6-Aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2- hydroxy-2-phenylacetamide: A Novel Muscarinic Antagonist with M2-Sparing Antagonistic Activity J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 790 - 797. [Abstract] [Full Text] |
||||
![]() |
D. B. Jacoby, B. L. Yost, B. Kumaravel, Y. Chan-Li, H.-Q. Xiao, K. Kawashima, and A. D. Fryer Glucocorticoid Treatment Increases Inhibitory M2 Muscarinic Receptor Expression and Function in the Airways Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 485 - 491. [Abstract] [Full Text] |
||||
![]() |
C. M. Evans, K. E. Belmonte, R. W. Costello, D. B. Jacoby, G. J. Gleich, and A. D. Fryer Substance P-induced airway hyperreactivity is mediated by neuronal M2 receptor dysfunction Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L477 - L486. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Adamko, B. L. Yost, G. J. Gleich, A. D. Fryer, and D. B. Jacoby Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection: Eosinophils Mediate Airway Hyperresponsiveness, M2 Muscarinic Receptor Dysfunction, and Antiviral Effects J. Exp. Med., November 15, 1999; 190(10): 1465 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Yost, G. J. Gleich, and A. D. Fryer Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein J Appl Physiol, October 1, 1999; 87(4): 1272 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. FRYER and D. B. JACOBY Muscarinic Receptors and Control of Airway Smooth Muscle Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S154 - S160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R W Costello, D B Jacoby, and A D Fryer Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity Thorax, July 1, 1998; 53(7): 613 - 618. [Full Text] |
||||
![]() |
A. Fryer, Y.-C. Huang, G. Rao, D. Jacoby, E. Mancilla, R. Whorton, C. A. Piantadosi, T. Kennedy, and J. Hoidal Selective O-Desulfation Produces Nonanticoagulant Heparin that Retains Pharmacological Activity in the Lung, J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 208 - 219. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |